Anneloes van Baar

Prof. Dr. Anneloes van Baar


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1999 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
VPVictor J. Pop
Victor J. Pop
JKJohannes L. Kuijpens
Johannes L. Kuijpens
Anneloes van BaarAnneloes van Baar
Anneloes van Baar
GVGerda Verkerk
Gerda Verkerk
MSMaarten M. van Son
Maarten M. van Son
HVHuib L. Vader
Huib L. Vader

1 February 2019 in The Lancet
Verified
Journal Article
Open access
MMMary Ellen McCann
Mary Ellen McCann
JGJurgen C de Graaff
Jurgen C de Graaff
LDLiam Dorris
Liam Dorris
NDNicola Disma
Nicola Disma
DWDavinia Withington
Davinia Withington
RWRobert Williams
Robert Williams
In laboratory animals, exposure to most general anaesthetics leads to neurotoxicity manifested by neuronal cell death and abnormal behaviour and cognition. Some large human cohort studies have shown an association between general anaesthesia at a young age and subsequent neurodevelopmental deficits, but these studies are prone to bias. Others have found no evidence for an association. We aimed to establish whether general anaesthesia in early infancy affects neurodevelopmental outcomes. In this international, assessor-masked, equivalence, randomised, controlled trial conducted at 28 hospitals in Australia, Italy, the USA, the UK, Canada, the Netherlands, and New Zealand, we recruited infants of less than 60 weeks' postmenstrual age who were born at more than 26 weeks' gestation and were undergoing inguinal herniorrhaphy, without previous exposure to general anaesthesia or risk factors for neurological injury. Patients were randomly assigned (1:1) by use of a web-based randomisation service to receive either awake-regional anaesthetic or sevoflurane-based general anaesthetic. Anaesthetists were aware of group allocation, but individuals administering the neurodevelopmental assessments were not. Parents were informed of their infants group allocation upon request, but were told to mask this information from assessors. The primary outcome measure was full-scale intelligence quotient (FSIQ) on the Wechsler Preschool and Primary Scale of Intelligence, third edition (WPPSI-III), at 5 years of age. The primary analysis was done on a per-protocol basis, adjusted for gestational age at birth and country, with multiple imputation used to account for missing data. An intention-to-treat analysis was also done. A difference in means of 5 points was predefined as the clinical equivalence margin. This completed trial is registered with ANZCTR, number ACTRN12606000441516, and ClinicalTrials.gov, number NCT00756600. Between Feb 9, 2007, and Jan 31, 2013, 4023 infants were screened and 722 were randomly allocated: 363 (50%) to the awake-regional anaesthesia group and 359 (50%) to the general anaesthesia group. There were 74 protocol violations in the awake-regional anaesthesia group and two in the general anaesthesia group. Primary outcome data for the per-protocol analysis were obtained from 205 children in the awake-regional anaesthesia group and 242 in the general anaesthesia group. The median duration of general anaesthesia was 54 min (IQR 41-70). The mean FSIQ score was 99·08 (SD 18·35) in the awake-regional anaesthesia group and 98·97 (19·66) in the general anaesthesia group, with a difference in means (awake-regional anaesthesia minus general anaesthesia) of 0·23 (95% CI -2·59 to 3·06), providing strong evidence of equivalence. The results of the intention-to-treat analysis were similar to those of the per-protocol analysis. Slightly less than 1 h of general anaesthesia in early infancy does not alter neurodevelopmental outcome at age 5 years compared with awake-regional anaesthesia in a predominantly male study population. US National Institutes of Health, US Food and Drug Administration, Thrasher Research Fund, Australian National Health and Medical Research Council, Health Technologies Assessment-National Institute for Health Research (UK), Australian and New Zealand College of Anaesthetists, Murdoch Children's Research Institute, Canadian Institutes of Health Research, Canadian Anesthesiologists Society, Pfizer Canada, Italian Ministry of Health, Fonds NutsOhra, UK Clinical Research Network, Perth Children's Hospital Foundation, the Stan Perron Charitable Trust, and the Callahan Estate.

14 August 2003 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
VPVictor Pop
Victor Pop
EBEvelien P. Brouwers
Evelien P. Brouwers
HVHuib L. Vader
Huib L. Vader
TVThomas Vulsma
Thomas Vulsma
Anneloes van BaarAnneloes van Baar
Anneloes van Baar
JVJan J. De Vijlder
Jan J. De Vijlder

1 April 2011 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
VBVeerle Bergink
Veerle Bergink
LKLibbe Kooistra
Libbe Kooistra
MBMijke P. Lambregtse-Van Den Berg
Mijke P. Lambregtse-Van Den Berg
HWHenny Wijnen
Henny Wijnen
RBRobertas Bunevicius
Robertas Bunevicius
VPVictor Pop
Victor Pop

2 January 1997 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
AWAleid G. van Wassenaer
Aleid G. van Wassenaer
JKJoke H. Kok
Joke H. Kok
JVJan J.M. de Vijlder
Jan J.M. de Vijlder
JBJudy M. Briët
Judy M. Briët
BSBert J. Smit
Bert J. Smit
TVThomas Vulsma
Thomas Vulsma
Premature infants who have transient hypothyroxinemia in the first weeks of life may have developmental delay and neurologic dysfunction. Whether thyroxine treatment during this period results in improved developmental outcomes is not known.

1 July 2009 in Pediatrics
Verified
Journal Article
Closed access
PDF file
Anneloes van BaarAnneloes van Baar
Anneloes van Baar
JVJohn Vermaas
John Vermaas
EKEdwin Knots
Edwin Knots
MKMartin J. K. de Kleine
Martin J. K. de Kleine
PSPaul Soons
Paul Soons
OBJECTIVE: To study outcome of low-risk moderately preterm birth between 32 and 36/7 weeks' gestation. METHODS: 377 Moderately preterm children (M: 34.7, SD: 1.2 complete weeks), without need for neonatal intensive care and without dysmaturity or congenital malformations, were compared with 182 term children and assessed at eight years (M: 8.9, SD: 0.54). School situation, IQ, sustained attention, behavior problems, and attention-deficit/hyperactivity characteristics were studied. RESULTS: Special education was attended by 7.7% of the moderately preterm children, more than twice the rate of 2.8% in the general Dutch population of this age. Additional exploration for two preterm subgroups of 32 to 33 versus 34 to 36 weeks' gestation showed a need for special education in 9.7% versus 7.3% and a significant difference in grade retention for 30% versus 17%, respectively. Of the children attending mainstream primary schools, grade retention was found in 19% of the preterm versus 8% of the comparison children. Adjusting for maternal education, a group difference of 3 points was found in IQ. The preterm children needed more time for the sustained attention task. The preterm children had more behavior problems (specifically internalizing problems with 27% scoring above the borderline cut-off), as well as more attention-deficit/hyperactivity disorder characteristics (specifically attention deficits). CONCLUSIONS: Cognitive and emotional regulation difficulties affect functioning of moderately preterm children, as school problems, a slightly lower IQ, attention and behavioral problems are found when they are compared with term-born children. Identification and monitoring of precursors of these problems at younger age is needed in view of prevention purposes.